Service 01 / 05
Market Access.
A structured path from product evaluation to local market presence — market and channel prioritisation, regulatory routes, launch sequencing and partner logic.
Market entry for pharmaceuticals, OTC products and food supplements is category-specific: what counts as a compliant claim, which notifications or authorisations apply, and which channels carry the product differ across Europe and Latin America. Our market-access service resolves these questions in a fixed sequence, so investment follows evidence — not assumptions.
Our approach
Evidence before investment.
Every engagement starts with an assessment of the product, its category and the realistic regulatory route. Only then do we sequence markets, prepare documentation and structure partners — so each step builds on validated ground.
Because we operate our own brands in European pharmacies and work through local partners in Latin America, our recommendations connect regulatory routes with current channel and partner requirements.
What you get.
Concrete deliverables — not a strategy deck that dies in a drawer.
-
Market & channel prioritisation
Which markets and channels first — based on category, claims and competition.
-
Regulatory route mapping
The compliant path: classification, notifications and authorisations where needed.
-
Launch sequencing
A staged plan from first market to expansion — no big-bang risk.
-
Partner shortlist & set-up
Distributors, pharmacy chains and e-commerce — qualified and contracted.
-
Quality readiness
Specifications and documentation aligned with the applicable product and distribution requirements.
-
Commercial launch support
Listing, sales enablement and launch execution with local teams.
Built for.
Three situations where this service pays for itself.
-
International brands
You have a proven product and need a compliant, structured entry into Europe or selected Latin American markets.
-
Regional portfolio expansion
You want to expand across Europe or into a selected Latin American market with an accountable local partner.
-
Portfolio owners
You hold rights to products but lack the operating structure to commercialise them locally.
Common questions.
Straight answers — the rest we cover on a call.
Which markets do you cover?
Switzerland and the DACH region directly; further European markets through qualified partners. In Latin America, AFZ works through partner and registration activities in Ecuador and Bolivia, with commercial development in Mexico.
Do you take the MAH role?
Only where legally applicable and mandated. Otherwise we coordinate with qualified partners who hold the appropriate authorisations.
How long does market entry take?
Category-dependent: food supplements typically move in months; medicinal products follow the regulatory route. The Assess phase gives you a realistic timeline first.
What does an engagement cost?
We scope after the first assessment — flexible models from project-based coordination to full market access.
Tell us your product and target markets.
You'll get a clear next step — not a generic brochure.
Services are scoped to the product, territory and responsibilities agreed with AFZ and qualified partners. National authorisations, MAH roles and reimbursement pathways apply only where legally applicable and explicitly mandated.